A massive research study that raised health concerns over hydroxychloroquine, the anti-malaria drug touted by President Trump
Donald John Trump Michael Flynn records expose plenty except criminal activity or collusion50 individuals jailed in Minneapolis as hundreds more Nationwide Guard troops deployed Missouri state legislator sparks reaction by tweeting ‘looters should have to be shot’ MORE as a coronavirus treatment, is coming under scrutiny from researchers who are requiring to see the information behind it.
The researchers revealed issues over a prominent study from The Lancet, which surveyed 96,000 hospitalized COVID-19 patients across six continents and concluded that the drug was ineffective in combating the coronavirus and caused severe heart problems and even death for clients who had the illness.
An open letter from more than 180 researchers worldwide raised issues over what they said was irregular data in the report, noting that the typical everyday dosages of hydroxychloroquine were greater than the those recommended by the U.S. Food and Drug Administration (FDA).
They also pointed out that information the magazine stated was from Australian patients did not seem to match information from the Australian federal government, among other things.
Another significant issue was that the research study’s authors did not release their code or information regardless of signing a promise to share details on the coronavirus.
The r